Cytheris And CITN Announce Selection Of Recombinant Interleukin-7 (CYT107) For Initial Studies At Member Institutions
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, and the Cancer Immunotherapy Trials Network (CITN), a new initiative in immunotherapy funded by the National Cancer Institute with its Central Operations and Statistical Center (COSC) headquartered at Fred Hutchinson Cancer Research Center, Seattle, Washington …
The Perfect Way To Naturally Increase Your Breast Size